Research Article

Stemness of Mesenchymal Stem Cells

Tong Ming Liu*

Published: 12/29/2017 | Volume 1 - Issue 1 | Pages: 071-073


Mesenchymal stem cells (MSCs) are multipotent adult stem cells that can self-renew and differentiate into a variety of cell types including chondrocytes, osteocytes and adipocytes. MSCs reside in bone marrow, adipose tissues, cord blood, peripheral blood, placenta, Wharton’s jelly, fetal liver and lung among others. MSCs represent one of the most promising stem cells for regenerative medicine due to their multipotency, immunoprivileged properties and easy expansion in vitro. So far, MSCs are already in various phases of clinical application [1-4]. Their most immediate use is in the orthopedic context due to the clear demonstration of their ability to differentiate into bone and cartilage [5-8]. It has been 5 decades since Friedenstein et al described clonal and plastic adherent stromal cells from bone marrow in the 1960s [9,10]. Although there are a handful of genes suggesting possible MSC stemness markers, the molecular basis underlying MSC stemness, especially the key transcription factor to MSC stemness, is still poorly understood.

Read Full Article HTML DOI: 10.29328/journal.jsctt.1001008 Cite this Article


  1. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002; 99: 8932-8937. Ref.:  
  2. Arinzeh TL, Peter SJ, Archambault MP, van den Bos C, Gordon S, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am. 2003; 85-A: 1927-1935. Ref.:  
  3. Shi M, Liu Z, Wang Y, Xu R, Sun Y, et al. A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection. Stem Cells Transl Med. 2017; 6: 2053-2061. Ref.:  
  4. Introna M, Lucchini G, Dander E, Galimberti S, Rovelli A, et al. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol Blood Marrow Transplant. 2014; 20: 375-381. Ref.:  
  5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147. Ref.:  
  6. Pountos I, Jones E, Tzioupis C, McGonagle D, Giannoudis PV. Growing bone and cartilage: The role of mesenchymal stem cells. J Bone Joint Surg Br. 2006; 88: 421-426. Ref.: 
  7. Liu TM, Guo XM, Tan HS, Hui JH, Lim B, et al. Zinc-finger protein 145, acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair. Arthritis Rheum. 2011; 63: 2711-2720. Ref.:  
  8. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, et al. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells. 2007; 25: 750-760. Ref.:  
  9. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966; 16: 381-390. Ref.:  
  10. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968; 2: 230-247. Ref.:  
  11. Mareddy S, Dhaliwal N, Crawford R, Xiao Y. Stem cell-related gene expression in clonal populations of mesenchymal stromal cells from bone marrow. Tissue Eng Part A. 2010; 16: 749-758. Ref.:   
  12. Menicanin D, Bartold PM, Zannettino AC, Gronthos S. Identification of a common gene expression signature associated with immature clonal mesenchymal cell populations derived from bone marrow and dental tissues. Stem Cells Dev. 2010; 19: 1501-1510. Ref.:   
  13. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One; 2008: 3: 2213. Ref.:  
  14. Liu TM, Ng WM, Tan HS, Vinitha D, Yang Z, et al. Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev. 2013; 22: 268-278. Ref.:  
  15. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem cells; 2004, 22: 675-682. Ref.:  
  16. Fotia C, Massa A, Boriani F, Baldini N, Granchi D. Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells. Cytotechnology. 2015; 67: 1073-1084. Ref.:  
  17. Hu X, Wu R, Shehadeh LA, Zhou Q, Jiang C, et al. Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells. BMC Genomics. 2014; 15: 303. Ref.:
  18. Drela K, Sarnowska A, Siedlecka P, Szablowska-Gadomska I, Wielgos M, et al. Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. Cytotherapy. 2014; 16: 881-892. Ref.:   
  19. Wong TY, Chang CH, Yu CH, Huang LLH. Hyaluronan keeps mesenchymal stem cells quiescent and maintains the differentiation potential over time. Aging Cell. 2017; 16: 451-460. Ref.:   
  20. Xiong Y, He J, Zhang W, Zhou G, Cao Y, et al. Retention of the stemness of mouse adipose-derived stem cells by their expansion on human bone marrow stromal cell-derived extracellular matrix. Tissue Eng Part A. 2015; 21: 1886-1894. Ref.:   
  21. Cesarz Z, Tamama K. Spheroid Culture of Mesenchymal Stem Cells. Stem Cells Int. 2016; 2016: 9176357. Ref.:   
  22. Obara C, Tomiyama K, Takizawa K, Islam R, Yasuda T, et al. Characteristics of three-dimensional prospectively isolated mouse bone marrow mesenchymal stem/stromal cell aggregates on nanoculture plates. Cell Tissue Res. 2016; 366: 113-127. Ref.:  
  23. Coutu DL, François M, Galipeau J. Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood. 2011; 117: 6801-6812. Ref.:
  24. Yu Y, Wei N, Stanford C, Schmidt T, Hong L. In vitro effects of RU486 on proliferation and differentiation capabilities of human bone marrow mesenchymal stromal cells. Steroids. 2012; 77: 132-137. Ref.:  
  25. Kubo H, Shimizu M, Taya Y, Kawamoto T, Michida M, et al. Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry. Genes Cells. 2009; 14: 407-424. Ref.:  
  26. Yuan Z, Zhang J, Huang Y, Zhang Y, Liu W, et al. NRF2 overexpression in mesenchymal stem cells induces stem-cell marker expression and enhances osteoblastic differentiation. Biochem Biophys Res Commun. 2017; 491: 228-235. Ref.:  
  27. Yu KR, Yang SR, Jung JW, Kim H, Ko K, et al. CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells. 2012; 30: 876-887. Ref.:  
  28. Fan Z, Yamaza T, Lee JS, Yu J, Wang S, et al. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol. 2009; 11: 1002-1009. Ref.: